Plasma proteomic signatures improve risk stratification and personalized screening for gastric cancer

Gastric Cancer · Published 2026-05-14 · DOI 10.1007/s10120-026-01749-4

Free full text

Authors (11)

Xue Li, Wen-Hao Shi, Juan Zhu, Ying Chen, Bin Liu, Nai-Ren Zheng, Le Wang, Li Yuan, Ying-Ying Mao, Xiang-Dong Cheng, Lingbin Du

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, X., Shi, W., Zhu, J., et al. (2026). Plasma proteomic signatures improve risk stratification and personalized screening for gastric cancer. Gastric Cancer. https://doi.org/10.1007/s10120-026-01749-4

Related articles

• Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines · Gastric Cancer · 2026 · Same journal
• Artificial intelligence–based anatomical recognition improves surgeon decision-making during robotic gastrectomy · Gastric Cancer · 2026 · Same journal
• Simple clinical parameters to identify sarcopenia 1 year after gastrectomy for gastric cancer · Gastric Cancer · 2026 · Same journal
• A proof-of-concept study of surgical-VLM for surgical support in robotic surgery: contextual benchmarking against ChatGPT-5 · Gastric Cancer · 2026 · Same journal
• Early- versus late-onset gastroesophageal cancer: real-world outcomes from a 13-year central European cohort study · Gastric Cancer · 2026 · Same journal
• Comment on ‘Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer’ · Gastric Cancer · 2026 · Same journal
• Racial/ethnic and geographic differences in second primary cancers in stomach cancer survivors: a comparative study of U.S. and South Korea · Gastric Cancer · 2026 · Same journal
• Total versus subtotal gastrectomy following neoadjuvant flot chemotherapy for distal diffuse gastric adenocarcinoma: an international cohort study · Gastric Cancer · 2026 · Same journal
• The whole-course of supervised home-based multi-modal prehabilitation to improve clinical outcome in patients undergoing neoadjuvant chemotherapy prior to gastrectomy: a single-center randomized controlled trial · Gastric Cancer · 2026 · Same journal
• Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities · Gastric Cancer · 2026 · Same journal